ClinicalTrials.Veeva
Menu

Find clinical trials for Acute Myeloid Leukemia (AML) in Kansas City, KS

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Acute Myeloid Leukemia
Leukemia
Myeloid Leukemia
Myelodysplastic Syndromes
Preleukemia
Chronic Myelomonocytic Leukemia
Syndrome

Acute Myeloid Leukemia (AML) trials near Kansas City, KS, USA:

Study of Iomab-B vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory Acute Myeloid Leukemia (SIERRA)

allogeneic hematopoietic stem cell transplant (HCT), versus Conventional Care in patients with Active, Relapsed or Refractory Acute Myeloid...

Active, not recruiting
AML
Acute Myelogenous Leukemia
Drug: Iomab-B
Drug: Conventional Care

Phase 3

Actinium Pharmaceuticals
Actinium Pharmaceuticals

Westwood, Kansas, United States and 23 other locations

study of five dose levels of APVO436 in combination with venetoclax and azacitidine (ven/aza) in adult patients with newly diagnosed, CD123+ AML...

Enrolling
Acute Myeloid Leukemia (AML)
Drug: Venetoclax
Drug: Azacitidine

Phase 1

Aptevo Therapeutics

Fairway, Kansas, United States and 6 other locations

AML that cannot or elect not to be treated with more intensive chemotherapy; (2) whether BP1001-based treatment provides greater efficacy (....

Enrolling
Acute Myeloid Leukemia (AML)
Drug: BP1001 plus decitabine
Drug: BP1001 in combination with Ventoclax plus decitabine

Phase 2

Bio-Path

Fairway, Kansas, United States and 8 other locations

\[GO\]) improves survival of children/adolescents/young adults with acute myeloid leukemia (AML) in 1st relapse w...

Enrolling
Acute Myeloid Leukemia
Drug: Venetoclax
Drug: Fludarabine

Phase 3

PedAL BCU, LLC

Kansas City, Missouri, United States and 85 other locations

Ziftomenib is an investigational drug in development for the treatment of patients with acute myeloid leukemia (AML...

Enrolling
Myeloid Sarcoma
Nucleophosmin 1-mutated Acute Myeloid Leukemia
Drug: Venetoclax
Drug: Cytarabine

Phase 1

Kura Oncology

Fairway, Kansas, United States and 43 other locations

in combination with venetoclax for the treatment of newly diagnosed acute myeloid leukemia (AML) in adults who ar...

Active, not recruiting
Acute Myeloid Leukemia
Drug: Decitabine and Cedazuridine (ASTX727)
Drug: Venetoclax

Phase 1, Phase 2

Taiho Pharma
Taiho Pharma

Kansas City, Missouri, United States and 33 other locations

This is a multi-center, randomized, double-blinded, placebo controlled trial.

Enrolling
Adult Acute Myeloid Leukemia
Drug: mocravimod

Phase 3

Priothera

Westwood, Kansas, United States and 104 other locations

An open-label, phase I, multi-center study to determine in relapsed/refractory (r/r) acute myeloid leukemia (AML)...

Enrolling
Acute Myeloid Leukemia
Myelodysplastic Syndrome
Biological: CYAD-02
Drug: ENDOXAN

Phase 1

Celyad Oncology

Fairway, Kansas, United States and 4 other locations

safe and if they have beneficial effects in treating patients with acute myeloid leukemia (AML) or acute ...

Enrolling
Acute Leukemia of Ambiguous Lineage
Refractory Acute Myeloid Leukemia
Drug: Revumenib
Drug: Methotrexate

Phase 1

St. Jude Children's Research Hospital
St. Jude Children's Research Hospital

Kansas City, Missouri, United States and 5 other locations

it is safe for participants with myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). It will study S...

Enrolling
Acute Myeloid Leukemia
Myelodysplastic Syndrome
Drug: SEA-CD70
Drug: azacitidine

Phase 1

Seagen, a wholly owned subsidiary of Pfizer

Kansas City, Kansas, United States and 55 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems